INTUITIVE SURGICAL INC (IUI1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:IUI1 - US46120E6023 - Common Stock

448.05 EUR

+2.2 (+0.49%)

Last: 1/26/2026, 7:00:00 PM

Fundamental Rating

Overall IUI1 gets a fundamental rating of 5 out of 10. We evaluated IUI1 against 63 industry peers in the Health Care Equipment & Supplies industry. IUI1 gets an excellent profitability rating and is at the same time showing great financial health properties. IUI1 is quite expensive at the moment. It does show a decent growth rate. This makes IUI1 very considerable for quality investing!

Quickly go to:

1. Profitability

1.1 Basic Checks

IUI1 had positive earnings in the past year.
In the past year IUI1 had a positive cash flow from operations.
IUI1 had positive earnings in 4 of the past 5 years.
IUI1 had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

IUI1 has a better Return On Assets (14.19%) than 92.06% of its industry peers.
IUI1 has a better Return On Equity (16.12%) than 84.13% of its industry peers.
The Return On Invested Capital of IUI1 (11.69%) is better than 84.13% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IUI1 is in line with the industry average of 9.95%.
The last Return On Invested Capital (11.69%) for IUI1 is above the 3 year average (9.53%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	14.19%
ROE	16.12%
ROIC	11.69%

ROA(3y)11.41%

ROA(5y)11.26%

ROE(3y)13.21%

ROE(5y)12.97%

ROIC(3y)9.53%

ROIC(5y)9.27%

1.3 Margins

IUI1 has a Profit Margin of 28.58%. This is amongst the best in the industry. IUI1 outperforms 98.41% of its industry peers.
IUI1's Profit Margin has declined in the last couple of years.
IUI1's Operating Margin of 29.44% is amongst the best of the industry. IUI1 outperforms 96.83% of its industry peers.
IUI1's Operating Margin has declined in the last couple of years.
IUI1 has a better Gross Margin (66.38%) than 73.02% of its industry peers.
IUI1's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	29.44%
PM (TTM)	28.58%
GM	66.38%

OM growth 3Y-4.19%

OM growth 5Y-1.68%

PM growth 3Y-2.34%

PM growth 5Y-2.02%

GM growth 3Y-0.91%

GM growth 5Y-0.58%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IUI1 is creating some value.
There is no outstanding debt for IUI1. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

There is no outstanding debt for IUI1. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	N/A

ROIC/WACC1.17

WACC10.02%

2.3 Liquidity

A Current Ratio of 4.97 indicates that IUI1 has no problem at all paying its short term obligations.
IUI1 has a better Current ratio (4.97) than 96.83% of its industry peers.
IUI1 has a Quick Ratio of 4.20. This indicates that IUI1 is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of IUI1 (4.20) is better than 96.83% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.97
Quick Ratio	4.2

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.83% over the past year.
The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth

EPS 1Y (TTM)21.83%

EPS 3Y23.94%

EPS 5Y21.42%

EPS Q2Q%14.48%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%18.76%

3.2 Future

The Earnings Per Share is expected to grow by 15.07% on average over the next years. This is quite good.
IUI1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.31% yearly.

EPS Next Y11.25%

EPS Next 2Y13.22%

EPS Next 3Y13.64%

EPS Next 5Y15.07%

Revenue Next Year15.2%

Revenue Next 2Y14.36%

Revenue Next 3Y13.92%

Revenue Next 5Y12.31%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 58.88 indicates a quite expensive valuation of IUI1.
Compared to the rest of the industry, the Price/Earnings ratio of IUI1 is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.25. IUI1 is valued rather expensively when compared to this.
IUI1 is valuated quite expensively with a Price/Forward Earnings ratio of 52.96.
69.84% of the companies in the same industry are cheaper than IUI1, based on the Price/Forward Earnings ratio.
IUI1 is valuated expensively when we compare the Price/Forward Earnings ratio to 25.98, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	58.88
Fwd PE	52.96

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IUI1 indicates a slightly more expensive valuation: IUI1 is more expensive than 66.67% of the companies listed in the same industry.
IUI1's Price/Free Cash Flow is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	82.11
EV/EBITDA	51.36

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IUI1 has a very decent profitability rating, which may justify a higher PE ratio.
IUI1's earnings are expected to grow with 13.64% in the coming years. This may justify a more expensive valuation.